ALFA FinderBSE filing, NSE: CONCORD. Summary written from the filing by ALFA Finder's alert engine.
Concord Drugs Ltd: key numbers
- Share price
- ₹71.11
- Market cap
- ₹93.69 Cr
- Revenue (annual)
- ₹78.74 Cr
- Net profit (annual)
- ₹1.06 Cr
- P/E (TTM)
- 45.7×Sector 43.8×
- Promoter holding
- 45.08%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Concord Drugs Ltd
All →Concord Drugs Other Announcement
Concord Drugs Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI regulations.
Concord Drugs Annual General Meeting
Concord Drugs Limited held its 31st Annual General Meeting on September 30, 2026. The meeting covered adoption of financial statements, director appointments, and auditor re-appointment.
Concord Drugs Other Announcement
Concord Drugs Limited is notifying shareholders about the annual report web-link as per Regulation 36(1)(b). Shareholders are urged to update their email addresses.
Concord Drugs Annual Report
Concord Drugs Limited submitted its 31st Annual Report for FY 2025-26 and notice of the 31st Annual General Meeting scheduled for 30th September 2026.
Concord Drugs Annual General Meeting
Concord Drugs approved the notice for its 31st AGM on September 30, 2026. The board also finalized director re-appointments and set book closure dates.
Concord Drugs Q1 FY27 Results: Net Profit ₹1.1 Cr, Up 1000.0% YoY
Concord Drugs Ltd reported revenue from operations of ₹20.9 Cr (+53.7% YoY) and net profit of ₹1.1 Cr (+1000.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.1 Cr · +1000.0% YoY
Other board meeting date announcements
All →Mitshi India Board Meeting Date
Mitshi India rescheduled its board meeting from 13 Nov to 14 Nov 2026 due to non-availability of directors. The meeting's agenda includes Q2/H1 2026 financial results approval.
Magnus Steel and Infra Board Meeting Date
Magnus Steel and Infra has scheduled its board for 14 Nov 2026 to approve standalone results for the quarter and half year ended 30 Sep 2026. The trading window is closed from 1 Oct 2026.
Ansal Properties & Infrastructure Board Meeting Date
Ansal Properties & Infrastructure intimated that its Board will meet on 18 Nov 2026 to approve Q1 FY27 standalone results. The meeting is scheduled and has not yet been held.
Boston Commerce Board Meeting Date
Boston Commerce Ltd scheduled its board meeting for 15 Nov 2026 to consider unaudited results for Q2 and Q1/H1 FY27. The trading window will remain closed until 48 hours after results declaration.
Associated Ceramics Board Meeting Date
Associated Ceramics has scheduled a board meeting on November 14, 2026 to consider unaudited standalone September 2026 half-yearly results. Advance notice; meeting not yet held.
Dudani Retail Board Meeting Date
Dudani Retail has given intimation of a board meeting on 14 November 2026 to consider unaudited half-year standalone results and related statements. The trading window stays closed until 48 hours after the results are declared.